Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for JANUX THERAPEUTICS INC
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-12-29
Sale
2021-12-30
9:00 pm
Janux Therapeutics Inc. JANX ORBIMED ADVISORS LLC
OrbiMed Capital GP VIII LLC
OrbiMed Genesis GP LLC
Director
40,400 $20.3 $820,120 231,098
(Indirect)
View
2021-12-29
Sale
2021-12-30
8:55 pm
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
40,400 $20.3 $820,120 231,098
(Indirect)
View
2021-12-21
Sale
2021-12-23
4:13 pm
Janux Therapeutics Inc. JANX ORBIMED ADVISORS LLC
OrbiMed Capital GP VIII LLC
OrbiMed Genesis GP LLC
Director
119,400 $19 $2,268,600 234,798
(Indirect)
View
2021-12-21
Sale
2021-12-23
4:08 pm
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
119,400 $19 $2,268,600 234,798
(Indirect)
View
2021-12-16
Sale
2021-12-17
5:16 pm
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
393,300 $19.07 $7,500,231 245,898
(Indirect)
View
2021-12-16
Sale
2021-12-17
5:13 pm
Janux Therapeutics Inc. JANX ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
393,300 $19.07 $7,500,231 245,898
(Indirect)
View
2021-06-15
Purchase
2021-06-16
6:22 pm
Janux Therapeutics Inc. JANX Bregua Corp
10% Owner
58,823 $17 $999,991 3,749,250
(Direct)
View
2021-06-15
Purchase
2021-06-16
6:20 pm
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
705,853 $17 $11,999,501 282,398
(Indirect)
View
2021-06-15
Purchase
2021-06-16
6:17 pm
Janux Therapeutics Inc. JANX ORBIMED ADVISORS LLC
OrbiMed Capital GP VIII LLC
OrbiMed Genesis GP LLC
Director
705,853 $17 $11,999,501 282,398
(Indirect)
View
2021-06-15
Purchase
2021-06-16
6:11 pm
Janux Therapeutics Inc. JANX Reardon Tighe
CFO
10% Owner
629,411 $17 $10,699,987 4,652,427
(Indirect
Direct)
View
2021-06-15
Purchase
2021-06-16
6:05 pm
Janux Therapeutics Inc. JANX Lichter Jay
Director
10% Owner
629,411 $17 $10,699,987 4,479,492
(Indirect)
View
2021-06-15
Purchase
2021-06-16
5:59 pm
Janux Therapeutics Inc. JANX Avalon Ventures XI L.P.
Avalon BioVentures SPV I L.P.
10% Owner
629,411 $17 $10,699,987 8,866,709
(Indirect
Direct)
View
2021-06-15
Purchase
2021-06-16
5:21 pm
Janux Therapeutics Inc. JANX RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
2,941,176 $17 $49,999,992 1,048,406
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-09-21
Option Award
2022-09-22
6:00 pm
N/A
2032-09-20
Janux Therapeutics Inc. JANX Kung Winston
Director
39,375 $0 39,375
(Direct)
View
2022-06-14
Option Award
2022-06-16
4:39 pm
N/A
2032-06-13
Janux Therapeutics Inc. JANX Barrett Ronald W
Director
12,500 $0 12,500
(Direct)
View
2022-06-14
Option Award
2022-06-16
4:37 pm
N/A
2032-06-13
Janux Therapeutics Inc. JANX CAPPS VICKIE L
Director
12,500 $0 12,500
(Direct)
View
2022-06-14
Option Award
2022-06-16
4:36 pm
N/A
2032-06-13
Janux Therapeutics Inc. JANX McNulty Alana B.
Director
12,500 $0 12,500
(Direct)
View
2022-06-14
Option Award
2022-06-16
4:35 pm
N/A
2032-06-13
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
12,500 $0 12,500
(Direct)
View
2022-06-14
Option Award
2022-06-16
4:33 pm
N/A
2032-06-13
Janux Therapeutics Inc. JANX Heller Stefan
Director
12,500 $0 12,500
(Direct)
View
2022-06-14
Option Award
2022-06-16
4:32 pm
N/A
2032-06-13
Janux Therapeutics Inc. JANX Gujrathi Sheila
Director
12,500 $0 12,500
(Direct)
View
2022-06-14
Option Award
2022-06-16
4:31 pm
N/A
2032-06-13
Janux Therapeutics Inc. JANX Lichter Jay
Director
10% Owner
12,500 $0 12,500
(Direct)
View
2022-06-14
Option Award
2022-06-16
4:30 pm
N/A
2032-06-13
Janux Therapeutics Inc. JANX RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
12,500 $0 12,500
(Indirect)
View
2022-06-14
Option Award
2022-06-16
4:30 pm
N/A
2032-06-13
Janux Therapeutics Inc. JANX Simson Jake
Director
12,500 $0 12,500
(Direct)
View
2022-03-01
Option Award
2022-03-03
5:06 pm
N/A
2032-02-29
Janux Therapeutics Inc. JANX Robinson Byron
Chief Strategy Officer
230,000 $0 230,000
(Direct)
View
2022-01-03
Option Award
2022-01-05
5:28 pm
N/A
2032-01-02
Janux Therapeutics Inc. JANX Salek-Ardakani Shahram
Chief Scientific Officer
114,250 $0 114,250
(Direct)
View
2022-01-03
Option Award
2022-01-05
5:27 pm
N/A
2032-01-02
Janux Therapeutics Inc. JANX Reardon Tighe
CFO
10% Owner
116,750 $0 116,750
(Direct)
View
2022-01-03
Option Award
2022-01-05
5:26 pm
N/A
2032-01-02
Janux Therapeutics Inc. JANX Meyer Andrew Hollman
Chief Business Officer
106,750 $0 106,750
(Direct)
View
2022-01-03
Option Award
2022-01-05
5:23 pm
N/A
2032-01-02
Janux Therapeutics Inc. JANX Godfrey Wayne
Chief Medical Officer
114,250 $0 114,250
(Direct)
View
2022-01-03
Option Award
2022-01-05
5:21 pm
N/A
2032-01-02
Janux Therapeutics Inc. JANX Campbell David Alan
CEO
354,250 $0 354,250
(Direct)
View
2021-09-07
Option Award
2021-09-09
5:36 pm
N/A
2031-09-06
Janux Therapeutics Inc. JANX McNulty Alana B.
Director
30,000 $0 30,000
(Direct)
View
2021-09-07
Option Award
2021-09-09
5:34 pm
N/A
2031-09-06
Janux Therapeutics Inc. JANX Barrett Ronald W
Director
30,000 $0 30,000
(Direct)
View
2021-07-12
Ownership
2021-07-20
4:44 pm
N/A
2031-05-13
Janux Therapeutics Inc. JANX Salek-Ardakani Shahram
Chief Scientific Officer
0 $0 416,325
(Direct)
View
2021-06-15
Conversion
2021-06-16
6:22 pm
N/A
N/A
Janux Therapeutics Inc. JANX Bregua Corp
10% Owner
6,571,323 $0 3,749,250
(Direct)
View
2021-06-15
Conversion
2021-06-16
6:20 pm
N/A
N/A
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
4,161,198 $0 282,398
(Indirect)
View
2021-06-15
Conversion
2021-06-16
6:17 pm
N/A
N/A
Janux Therapeutics Inc. JANX ORBIMED ADVISORS LLC
OrbiMed Capital GP VIII LLC
OrbiMed Genesis GP LLC
Director
4,161,198 $0 282,398
(Indirect)
View
2021-06-15
Conversion
2021-06-16
6:11 pm
N/A
N/A
Janux Therapeutics Inc. JANX Reardon Tighe
CFO
10% Owner
6,855,609 $0 4,652,427
(Indirect)
View
2021-06-15
Conversion
2021-06-16
6:05 pm
N/A
N/A
Janux Therapeutics Inc. JANX Lichter Jay
Director
10% Owner
14,325,514 $0 4,479,492
(Indirect)
View
2021-06-15
Conversion
2021-06-16
5:59 pm
N/A
N/A
Janux Therapeutics Inc. JANX Avalon Ventures XI L.P.
Avalon BioVentures SPV I L.P.
10% Owner
14,325,514 $0 8,866,709
(Direct)
View
2021-06-15
Conversion
2021-06-16
5:21 pm
N/A
N/A
Janux Therapeutics Inc. JANX RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
10,202,121 $0 1,048,406
(Indirect)
View
2021-06-10
Option Award
2021-06-14
5:43 pm
N/A
2031-06-09
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
10% Owner
30,000 $0 30,000
(Direct)
View
2021-06-10
Option Award
2021-06-14
5:40 pm
N/A
2031-06-09
Janux Therapeutics Inc. JANX Simson Jake
Director
30,000 $0 30,000
(Direct)
View
2021-06-10
Option Award
2021-06-14
5:37 pm
N/A
2031-06-09
Janux Therapeutics Inc. JANX Lichter Jay
Director
10% Owner
30,000 $0 30,000
(Direct)
View
2021-06-10
Ownership
2021-06-10
7:35 pm
N/A
N/A
Janux Therapeutics Inc. JANX ORBIMED ADVISORS LLC
OrbiMed Capital GP VIII LLC
OrbiMed Genesis GP LLC
Director
0 $0 2,336,911
(Indirect)
View
Goto 0, 1, Next